8-K: Superior Group Reports Q2 2026 Results: Sales Up, Adjusted EBITDA Grows
Quarterly Results
Superior Group of Companies announced its second quarter 2026 financial results, reporting an increase in total net sales and a rise in adjusted EBITDA, while also confirming its full-year outlook.
Summary
- Total net sales for the second quarter of 2026 reached $147.8 million, an increase from $144.0 million in the same quarter of 2025.
- Net income for the quarter was $1.2 million ($0.08 per diluted share), down from $1.6 million ($0.10 per diluted share) in Q2 2025.
- A non-cash tradename impairment charge of $2.6 million ($2.0 million after tax, or $0.13 per diluted share) was recorded in the Healthcare Apparel segment.
- Adjusted EBITDA increased to $7.7 million from $6.1 million in the prior year's second quarter.
- Adjusted net income, excluding the impairment charge, was $3.2 million ($0.21 per diluted share), up from $1.6 million ($0.10 per diluted share) in Q2 2025.
- The company confirmed its full-year 2026 outlook for net sales between $572.0 million and $585.0 million, and adjusted earnings per diluted share between $0.54 and $0.66.
- The Board of Directors approved a quarterly dividend of $0.14 per share.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive report, with revenue growth and improved adjusted EBITDA, but tempered by a net income decrease and a significant non-cash impairment charge.
Positives
- Total net sales increased by 2.6% to $147.8 million in Q2 2026 compared to $144.0 million in Q2 2025.
- Adjusted EBITDA grew by 25.8% to $7.7 million in Q2 2026, up from $6.1 million in Q2 2025.
- Adjusted net income more than doubled to $3.2 million ($0.21 per diluted share) in Q2 2026, compared to $1.6 million ($0.10 per diluted share) in Q2 2025.
- The company confirmed its full-year 2026 net sales outlook of $572.0 million to $585.0 million, representing growth from $566.2 million in 2025.
- Full-year 2026 adjusted earnings per diluted share outlook is projected between $0.54 and $0.66, an increase from $0.46 in 2025.
- A quarterly dividend of $0.14 per share was declared, indicating a commitment to shareholder returns.
Negatives
- Reported net income decreased to $1.2 million ($0.08 per diluted share) in Q2 2026 from $1.6 million ($0.10 per diluted share) in Q2 2025.
- A significant non-cash tradename impairment charge of $2.6 million ($2.0 million net of tax) was recognized in the Healthcare Apparel segment.
- The impairment charge reduced reported net income by $0.13 per diluted share.
Risks
- The impact of competition.
- The impact of global conflicts, such as the Russia-Ukraine War and the joint U.S.-Israeli War with Iran in 2026.
- Uncertainties related to tariffs, duties, trade wars and related matters.
- Supply disruptions and inflationary environments, including shipping costs and the cost of finished goods and raw materials.
- Employment levels, including labor shortages.
- General economic and political conditions in operating regions and sourcing areas.
- Changes in the healthcare, retail chain, food service, transportation, and other industries where uniforms and service apparel are worn.
- The ability to identify suitable acquisition targets, discover liabilities, and successfully integrate acquired businesses.
Future Outlook
The company forecasts full-year 2026 net sales in the range of $572.0 million to $585.0 million, an increase from $566.2 million in 2025. Full-year adjusted earnings per diluted share are projected to be between $0.54 and $0.66, up from $0.46 in 2025. The company anticipates stronger results in the second half of the year due to seasonal factors.
Management Comments
- "We've demonstrated the earnings power of our diversified business with Branded Products performing especially well this quarter, resulting in an adjusted EPS that was more than double the prior years second quarter."
- "We are navigating through soft market conditions, and we see growth opportunities ahead for all three of our attractive businesses."
- "Our guidance continues to reflect stronger results in the back half of the year given seasonal factors."
- "Ultimately, our diverse end markets, high customer retention and flexible supply chain combined with our healthy balance sheet allows us to drive continued growth and optimize shareholder value including through our attractive dividend yield and opportunistic share repurchases."
Industry Context
StockSavvy.ai notes that Superior Group of Companies operates in diverse markets including Healthcare Apparel, Branded Products, and Contact Centers. The reported results reflect a challenging macroeconomic environment with 'soft market conditions' but highlight the company's strategy of leveraging diversification and operational flexibility to drive growth and shareholder value.
Stakeholder Impact
- Shareholders: Benefit from a confirmed quarterly dividend of $0.14 per share and potential value optimization through share repurchases and company growth.
- Employees: May be impacted by labor shortage risks mentioned in the filing.
- Suppliers: Could be affected by supply chain disruptions and inflationary pressures on raw material costs.
- Creditors: The company's healthy balance sheet and confirmed outlook may provide confidence, though risks like economic conditions could be a concern.
Next Steps
- Continue to navigate soft market conditions.
- Pursue growth opportunities across all three business segments.
- Drive continued growth and optimize shareholder value.
- Utilize opportunistic share repurchases.
- Focus on enhancing shareholder value through organic growth and strategic acquisitions.
Key Dates
| Date | Description |
|---|---|
| 2026-06-30 | End of the second quarter for which results are reported. |
| 2026-08-04 | Date of the Form 8-K filing and the press release announcing Q2 2026 results. |
| 2026-08-14 | Record date for the quarterly dividend. |
| 2026-08-18 | End date for the telephone replay of the conference call. |
| 2026-08-28 | Payment date for the quarterly dividend. |
Recommendation
holdThe company demonstrates revenue growth and improved adjusted EBITDA, along with a confirmed full-year outlook and a consistent dividend. However, the decrease in reported net income due to a significant impairment charge, coupled with ongoing risks related to market conditions and global uncertainties, suggests a 'hold' position until further clarity on sustained operational improvements and risk mitigation emerges.
Keywords
apparel, healthcare apparel, branded products, contact centers, net sales, adjusted EBITDA, net income, dividend
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.